58 results
8-K
EX-99.2
GRTS
Gritstone Bio Inc
4 Jan 22
Other Events
5:21pm
0009 F 75 23 0014 M 75 27 0015 M 72 22
samRNA Boost was Shown to Have a Favorable Safety and Tolerability Profile at 10µg in Healthy Volunteers ≥60 … yrs No unexpected reactogenicity or safety events 1 AE of recurrence of asthma and 1 AE of recurrence of muscle spasm in 10 µg dose cohort Database
10-K
2018 FY
GRTS
Gritstone Bio Inc
28 Mar 19
Annual report
4:01pm
. The Phase 1 portion of our Phase 1/2 trial will seek to establish a dose for further investigation in Phase 2 and to evaluate safety, tolerability … and, importantly, immunogenicity of our lead product candidate. We will seek to further evaluate efficacy and safety in the Phase 2 cohort expansion
8-K
EX-99.1
niscqo514
4 Jan 22
Other Events
5:21pm
8-K
EX-99.1
g9j2zm7o
13 Jul 20
Other Events
4:07pm
DRS
zho2jbz8y6fh
28 Dec 18
Draft registration statement
12:00am
424B4
z9pwr
1 Oct 18
Prospectus supplement with pricing info
12:00am
DRS/A
cv8d yradid4z
13 Aug 18
Draft registration statement (amended)
12:00am
DRS/A
6lnsgi0yu1gx
9 Jul 18
Draft registration statement (amended)
12:00am
8-K
EX-99.1
ijbvp9ss2wavxv0nk 71
13 Jan 20
Other Events
6:15am
8-K
EX-99.1
d45unzj7 bj68d2102jz
13 Dec 19
Other Events
5:02pm